These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

745 related items for PubMed ID: 16890590

  • 1. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
    Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, Weishauss O, Spector L, Shtevi A, Altstock RT, Dotan N, Halpern Z.
    Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
    [Abstract] [Full Text] [Related]

  • 2. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1143-52. PubMed ID: 15569117
    [Abstract] [Full Text] [Related]

  • 3. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH, Stempak JM, Xu W, Lan H, Griffiths AM, Greenberg GR, Steinhart AH, Dotan N, Silverberg MS.
    Am J Gastroenterol; 2009 Jun 15; 104(6):1426-34. PubMed ID: 19491856
    [Abstract] [Full Text] [Related]

  • 4. Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort.
    Malickova K, Lakatos PL, Bortlik M, Komarek V, Janatkova I, Lukas M.
    Eur J Gastroenterol Hepatol; 2010 Feb 15; 22(2):144-50. PubMed ID: 19927001
    [Abstract] [Full Text] [Related]

  • 5. Serologies in Crohn's disease: can we change the gray zone to black and white?
    Abreu MT.
    Gastroenterology; 2006 Aug 15; 131(2):664-7. PubMed ID: 16890618
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?
    Castellino F, Rosina F, Bansi DS, Bauducci M, Touscoz GA, Giorda L, Borghesio E, Bessone MP, Astegiano M, Musso A.
    Eur J Gastroenterol Hepatol; 1995 Sep 15; 7(9):859-64. PubMed ID: 8574718
    [Abstract] [Full Text] [Related]

  • 9. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, Szamosi T, Papp J, Hungarian IBD Study Group, Lakatos PL.
    Am J Gastroenterol; 2008 Mar 15; 103(3):665-81. PubMed ID: 18047543
    [Abstract] [Full Text] [Related]

  • 10. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov 15; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 11. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
    Kiliç ZM, Tunç B, Ayaz S, Filik L, Aktaş S, Parlak E, Ulker A.
    Turk J Gastroenterol; 2004 Dec 15; 15(4):238-42. PubMed ID: 16249978
    [Abstract] [Full Text] [Related]

  • 12. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study.
    Annese V, Andreoli A, Andriulli A, Dinca R, Gionchetti P, Latiano A, Lombardi G, Piepoli A, Poulain D, Sendid B, Colombel JF.
    Am J Gastroenterol; 2001 Aug 15; 96(8):2407-12. PubMed ID: 11513182
    [Abstract] [Full Text] [Related]

  • 13. New serologic markers for inflammatory bowel disease diagnosis.
    Dotan I.
    Dig Dis; 2010 Aug 15; 28(3):418-23. PubMed ID: 20926866
    [Abstract] [Full Text] [Related]

  • 14. Novel anti-carbohydrate autoantibodies in patients with inflammatory bowel disease: are they useful for clinical practice?
    Malickova K, Lukas M, Donoval R, Sandova P, Janatkova I.
    Clin Lab; 2006 Aug 15; 52(11-12):631-8. PubMed ID: 17175895
    [Abstract] [Full Text] [Related]

  • 15. [Serodiagnosis of Crohn's disease].
    Auer IO, Wensinck F, Röder A, Merwe JP, Schmidt H, Schuster S.
    Dtsch Med Wochenschr; 1983 Aug 19; 108(33):1242-6. PubMed ID: 6872878
    [Abstract] [Full Text] [Related]

  • 16. Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).
    Schoepfer AM, Flogerzi B, Seibold-Schmid B, Schaffer T, Kun JF, Pittet V, Mueller S, Seibold F.
    Am J Gastroenterol; 2009 Oct 19; 104(10):2508-16. PubMed ID: 19532127
    [Abstract] [Full Text] [Related]

  • 17. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A, Gasiorowska A, Małecka-Panas E.
    Pol Merkur Lekarski; 2004 Oct 19; 17 Suppl 1():22-6. PubMed ID: 15603341
    [Abstract] [Full Text] [Related]

  • 18. Alterations in serum anti-alpha-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis.
    D'Alessandro M, Mariani P, Lomanto D, Bachetoni A, Speranza V.
    Clin Immunol; 2002 Apr 19; 103(1):63-8. PubMed ID: 11987986
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases.
    Colombel JF, Reumaux D, Duthilleul P, Noël LH, Gower-Rousseau C, Paris JC, Cortot A.
    Gastroenterol Clin Biol; 1992 Apr 19; 16(8-9):656-60. PubMed ID: 1426820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.